PGD2-inhibitor
CAS No. 885066-67-1
PGD2-inhibitor ( MDK66671; MDK-66671 MDK 66671 )
Catalog No. M19229 CAS No. 885066-67-1
MDK66671 is a prostaglandin D2(PGD2) inhibitor. MDK66671 has CAS#885066-67-1, in which the last five digit was used in its name.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 146 | In Stock |
|
10MG | 246 | In Stock |
|
25MG | 413 | In Stock |
|
50MG | 609 | In Stock |
|
100MG | 867 | In Stock |
|
500MG | 1737 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePGD2-inhibitor
-
NoteResearch use only, not for human use.
-
Brief DescriptionMDK66671 is a prostaglandin D2(PGD2) inhibitor. MDK66671 has CAS#885066-67-1, in which the last five digit was used in its name.
-
DescriptionMDK66671 is a prostaglandin D2(PGD2) inhibitor. MDK66671 has CAS#885066-67-1, in which the last five digit was used in its name.
-
SynonymsMDK66671; MDK-66671 MDK 66671
-
PathwayOthers
-
TargetOther Targets
-
RecptorPGD2(DP)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number885066-67-1
-
Formula Weight460.35
-
Molecular FormulaC23H23Cl2N3O3
-
Purity98%
-
SolubilityDMSO : ≥ 25 mg/mL; 54.31 mM
-
SMILESCOc2nc(cc(NCCc1ccc(Cl)cc1Cl)n2)c3cccc(c3)C(C)(C)C(=O)O
-
Chemical Name2-(3-(6-((2,4-dichlorophenethyl)amino)-2-methoxypyrimidin-4-yl)phenyl)-2-methylpropanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mu L, et al. Understanding DP receptor antagonism using a CoMSIA approach. Bioorg Med Chem Lett. 2011 Jan 1;21(1):66-75.
molnova catalog
related products
-
TMB
TMB is a chromogenic substrate. It used in staining procedures in immunohistochemistry and a visualizing reagent used in ELISA.
-
1-Chloroindan
1-Chloroindan.Reference standards.
-
CEF19,Epstein-Barr V...
CEF19, Epstein-Barr Virus latent NA-3A (458-466) is a single peptide epitope, YPLHEQHGM, representing residues 458-466 of the type 1 Epstein-Barr Virus (EBV) nuclear antigen 3A protein (B95.8 strain).